VOYA Investment Management
AURA icon

VOYA Investment Management’s Aura Biosciences AURA Stock Holding History

VOYA Investment Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,582
Closed -$85K – 2457
2025
Q2 		$85K Hold
13,582
– – ﹤0.01% 2519
2025
Q1 		$79.6K Sell
13,582
-1,459
-10% -$11K ﹤0.01% 2473
2024
Q4 		$124K Sell
15,041
-959
-6% -$9.03K ﹤0.01% 2526
2024
Q3 		$143K Sell
16,000
-148
-0.9% -$1.27K ﹤0.01% 2572
2024
Q2 		$122K Buy
+16,148
New +$118K ﹤0.01% 2617
2024
Q1 		– Sell
-11,786
Closed -$104K – 2789
2023
Q4 		$104K Hold
11,786
– – ﹤0.01% 2749
2023
Q3 		$106K Buy
11,786
+475
+4% +$5.11K ﹤0.01% 2715
2023
Q2 		$140K Buy
+11,311
New +$121K ﹤0.01% 2699

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VOYA Investment Management's AURA Position: Q3 2025 in Review

VOYA Investment Management sold out of Aura Biosciences (AURA) in Q3 2025, closing a stake of 13,582 shares — an estimated $85K sold.

VOYA Investment Management first reported a position in AURA in Q2 2023 and held it in 8 quarters. The position peaked at $143K in Q3 2024. 106 funds tracked by Wall St. Rank hold AURA as of Q3 2025.

  • VOYA Investment Management reported no remaining Aura Biosciences position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 13,582 Aura Biosciences shares in Q3 2025, an estimated $85K.
  • VOYA Investment Management first reported a position in Aura Biosciences in Q2 2023 and held it in 8 quarters.
  • VOYA Investment Management's Aura Biosciences position peaked at $143K in Q3 2024.
  • 106 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.